Skip to Content
Merck
  • Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease.

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease.

Nature communications (2020-04-15)
Lisa Mayr, Felix Grabherr, Julian Schwärzler, Isabelle Reitmeier, Felix Sommer, Thomas Gehmacher, Lukas Niederreiter, Gui-Wei He, Barbara Ruder, Kai T R Kunz, Piotr Tymoszuk, Richard Hilbe, David Haschka, Clemens Feistritzer, Romana R Gerner, Barbara Enrich, Nicole Przysiecki, Markus Seifert, Markus A Keller, Georg Oberhuber, Susanne Sprung, Qitao Ran, Robert Koch, Maria Effenberger, Ivan Tancevski, Heinz Zoller, Alexander R Moschen, Günter Weiss, Christoph Becker, Philip Rosenstiel, Arthur Kaser, Herbert Tilg, Timon E Adolph
ABSTRACT

The increased incidence of inflammatory bowel disease (IBD) has become a global phenomenon that could be related to adoption of a Western life-style. Westernization of dietary habits is partly characterized by enrichment with the ω-6 polyunsaturated fatty acid (PUFA) arachidonic acid (AA), which entails risk for developing IBD. Glutathione peroxidase 4 (GPX4) protects against lipid peroxidation (LPO) and cell death termed ferroptosis. We report that small intestinal epithelial cells (IECs) in Crohn's disease (CD) exhibit impaired GPX4 activity and signs of LPO. PUFAs and specifically AA trigger a cytokine response of IECs which is restricted by GPX4. While GPX4 does not control AA metabolism, cytokine production is governed by similar mechanisms as ferroptosis. A PUFA-enriched Western diet triggers focal granuloma-like neutrophilic enteritis in mice that lack one allele of Gpx4 in IECs. Our study identifies dietary PUFAs as a trigger of GPX4-restricted mucosal inflammation phenocopying aspects of human CD.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PD 146176, ≥98% (HPLC), solid
Sigma-Aldrich
all-cis-7,10,13,16,19-Docosapentaenoic acid, synthetic, ≥97%
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide 2′-phosphate reduced tetrasodium salt hydrate, ≥97% (HPLC)
Sigma-Aldrich
Collagenase from Clostridium histolyticum, 0.2 μm filtered, suitable for release of physiologically active rat hepatocytes, Type IV-S, 0.5-5.0 FALGPA units/mg solid, ≥125 CDU/mg solid
Sigma-Aldrich
Iron(III) sulfate hydrate, BioReagent, suitable for plant cell culture
Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Sigma-Aldrich
Palmitoleic acid, ≥98.5% (GC), liquid
Sigma-Aldrich
Deoxyribonuclease II from bovine spleen, Type V, essentially salt-free, lyophilized powder, ≥1,000 units/mg protein
Sigma-Aldrich
Lipopolysaccharides from Escherichia coli O55:B5, purified by ion-exchange chromatography, TLR ligand tested
Sigma-Aldrich
(±)-α-Tocopherol, synthetic, ≥96% (HPLC)
Sigma-Aldrich
Anti-Actin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Deferoxamine mesylate salt, powder, ≥92.5% (TLC)
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Supelco
Palmitoleic acid, analytical standard
Sigma-Aldrich
2-(Diisopropylamino)ethyl methacrylate, 97%, contains ~100 ppm monomethyl ether hydroquinone as inhibitor
Sigma-Aldrich
MISSION® esiRNA, targeting human GPX4
Sigma-Aldrich
Zileuton, ≥98% (HPLC)
Sigma-Aldrich
Deferasirox, ≥98% (HPLC)
Sigma-Aldrich
NCTT-956, ≥97% (NMR)
Sigma-Aldrich
ML351, ≥98% (HPLC)
Sigma-Aldrich
Arachidonic acid, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
Arachidonic acid, >95.0% (GC)
Sigma-Aldrich
Bay 11-7082, ≥98% (HPLC), powder
Sigma-Aldrich
β-Thujaplicin, 99%
Sigma-Aldrich
Cumene hydroperoxide, technical grade, 80%
Sigma-Aldrich
Deoxycholic acid, ≥98% (HPLC)
Sigma-Aldrich
cis-4,7,10,13,16,19-Docosahexaenoic acid, ≥98%
Sigma-Aldrich
cis-5,8,11,14,17-Eicosapentaenoic acid, ≥99%
Sigma-Aldrich
Oleic acid, ≥99% (GC)